NASDAQ:PLSE Pulse Biosciences (PLSE) Stock Price, News & Analysis $21.84 +0.01 (+0.05%) (As of 10:38 AM ET) Add Compare Share Share Today's Range$21.28▼$22.2150-Day Range$9.97▼$21.8352-Week Range$3.78▼$22.21Volume39,214 shsAverage Volume215,900 shsMarket Capitalization$1.21 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Pulse Biosciences alerts: Email Address Pulse Biosciences MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish23.93% of Float Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews Sentiment0.70Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.85 out of 5 starsMedical Sector836th out of 924 stocksSurgical & Medical Instruments Industry90th out of 97 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Pulse Biosciences.Read more about Pulse Biosciences' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted23.93% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently increased by 3.93%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldPulse Biosciences does not currently pay a dividend.Dividend GrowthPulse Biosciences does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePulse Biosciences has received a 61.90% net impact score from Upright. Pulse Biosciences seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Taxes". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Diagnostic and treatment machines", "Medical devices engineering", and "Clinical research services for cancer" products. See details.Environmental SustainabilityThe Environmental Impact score for Pulse Biosciences is -0.60. Previous Next 3.7 News and Social Media Coverage News SentimentPulse Biosciences has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.Search Interest3 people have searched for PLSE on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows1 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pulse Biosciences insiders have not sold or bought any company stock.Percentage Held by Insiders71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pulse Biosciences' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Pulse Biosciences is -26.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pulse Biosciences is -26.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPulse Biosciences has a P/B Ratio of 26.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaThis Crypto Is Set to Explode in AugustWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Industry Giants are Investing Heavily in Blockchain Technology and THIS COIN is at the Heart of Their Strategy. It's a groundbreaking opportunity that could be poised for extraordinary gains. Go here to get full details on this crypto now. About Pulse Biosciences Stock (NASDAQ:PLSE)Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Read More PLSE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PLSE Stock News HeadlinesAugust 21 at 12:05 PM | seekingalpha.comPacific Biosciences: A Speculative Play On Long-Read Genomics SequencingAugust 21 at 12:05 PM | finance.yahoo.comPLSE Sep 2024 15.000 call (PLSE240920C00015000)August 22, 2024 | Crypto 101 Media (Ad)This Crypto Is Set to Explode in AugustWith the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the latest DeFi craze or the next hot meme coin, the savviest investors are quietly positioning themselves for a different kind of explosion. This year's Bitcoin halving bull run is about to unleash a tidal wave in a completely undervalued sector of the crypto market.August 21 at 12:05 PM | finance.yahoo.comPLSE Sep 2024 16.000 put (PLSE240920P00016000)August 17, 2024 | ca.finance.yahoo.comPLSE Sep 2024 19.000 callAugust 12, 2024 | marketwatch.comStocks to Watch: BuzzFeed, FreightCar America, Pulse BioscienceAugust 12, 2024 | marketwatch.comPulse Bioscience Shares Rise After Business Update, Naming of Co-ChairmanAugust 12, 2024 | finance.yahoo.comPulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial ResultsAugust 22, 2024 | Crypto 101 Media (Ad)This Crypto Is Set to Explode in AugustWith the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the latest DeFi craze or the next hot meme coin, the savviest investors are quietly positioning themselves for a different kind of explosion. This year's Bitcoin halving bull run is about to unleash a tidal wave in a completely undervalued sector of the crypto market.August 12, 2024 | finance.yahoo.comPulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of DirectorsAugust 12, 2024 | finance.yahoo.comPLSE Aug 2024 14.000 call (PLSE240816C00014000)August 8, 2024 | finance.yahoo.comPulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery SystemAugust 1, 2024 | businesswire.comPulse Biosciences, Inc. Announces Participation in Upcoming Investor ConferencesAugust 1, 2024 | prnewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Pulse Biosciences, Inc. (NASDAQ: PLSE)July 28, 2024 | uk.investing.comPulse Biosciences Inc (PLSE)July 22, 2024 | seekingalpha.comHealthcare 2024 Second Half OutlookJuly 3, 2024 | businesswire.comPulse Biosciences, Inc. Announces the Closing of its Rights OfferingJune 4, 2024 | businesswire.comPulse Biosciences, Inc. Announces Commencement of Rights OfferingSee More Headlines Receive PLSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/30/2023Today8/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PLSE CUSIPN/A CIK1625101 Webwww.pulsebiosciences.com Phone(510) 906-4600FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-86.15% Return on Assets-66.87% Debt Debt-to-Equity RatioN/A Current Ratio7.06 Quick Ratio7.06 Sales & Book Value Annual Sales$700,000.00 Price / Sales1,722.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book26.95Miscellaneous Outstanding Shares55,225,000Free Float15,739,000Market Cap$1.21 billion OptionableOptionable Beta1.75 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Robert W. Duggan (Age 79)Executive Chairman Key CompetitorsSeaSpineNASDAQ:SPNEUtah Medical ProductsNASDAQ:UTMDAccurayNASDAQ:ARAYCytosorbentsNASDAQ:CTSOUFP TechnologiesNASDAQ:UFPTView All CompetitorsInsiders & InstitutionsAQR Capital Management LLCSold 1,766 shares on 8/15/2024Ownership: 0.018%Inspire Investing LLCSold 8,725 shares on 8/12/2024Ownership: 0.059%Renaissance Technologies LLCSold 16,000 shares on 8/9/2024Ownership: 0.082%Quest Partners LLCBought 8,134 shares on 8/6/2024Ownership: 0.013%Rhumbline AdvisersBought 1,608 shares on 8/1/2024Ownership: 0.042%View All Insider TransactionsView All Institutional Transactions PLSE Stock Analysis - Frequently Asked Questions How have PLSE shares performed this year? Pulse Biosciences' stock was trading at $12.24 on January 1st, 2024. Since then, PLSE stock has increased by 78.3% and is now trading at $21.83. View the best growth stocks for 2024 here. How were Pulse Biosciences' earnings last quarter? Pulse Biosciences, Inc. (NASDAQ:PLSE) released its earnings results on Thursday, March, 30th. The company reported ($0.24) earnings per share for the quarter. The business earned ($0.01) million during the quarter. What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO? 2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. When did Pulse Biosciences IPO? Pulse Biosciences (PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO. Who are Pulse Biosciences' major shareholders? Pulse Biosciences' top institutional investors include Griffin Asset Management Inc. (0.47%), Westside Investment Management Inc. (0.12%), Bank of New York Mellon Corp (0.08%) and Renaissance Technologies LLC (0.08%). Insiders that own company stock include Mitchell E Levinson, Kevin Patrick Danahy and Burke Thomas Barrett. View institutional ownership trends. How do I buy shares of Pulse Biosciences? Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Pulse Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA) and Portola Pharmaceuticals (PTLA). This page (NASDAQ:PLSE) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredThis Crypto Is Set to Explode in AugustWith the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the...Crypto 101 Media | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThis One stock is all you need...What if you could ignore 99% of the stock market... And retire on just ONE ticker?Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
